Squarepoint’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
Other funds holding TNYA
RS
Squarepoint's TNYA Position: Q3 2026 in Review
Squarepoint reduced its Tenaya Therapeutics (TNYA) stake by 85% in Q3 2026, selling an estimated $407K and leaving 101,066 shares worth $61K. The position accounts for ﹤0.01% of the portfolio, ranked #4272.
Squarepoint first reported a position in TNYA in Q4 2022 and has held it in 13 quarters since. The position peaked at $487K in Q2 2026. 33 funds tracked by Wall St. Rank hold TNYA as of Q3 2026.
- Squarepoint held 101,066 shares of Tenaya Therapeutics worth $61K as of Q3 2026.
- Squarepoint sold 558,181 Tenaya Therapeutics shares in Q3 2026, an estimated $407K.
- Tenaya Therapeutics made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #4272 holding.
- Squarepoint first reported a position in Tenaya Therapeutics in Q4 2022 and has held it in 13 quarters since.
- Squarepoint's Tenaya Therapeutics position peaked at $487K in Q2 2026.
- 33 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2026.
Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.